These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8047400)

  • 1. [Treatment of primary tuberculosis in children].
    Bourrillon A
    Pediatrie; 1993; 48(12):888-93. PubMed ID: 8047400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concept in the diagnosis and treatment of childhood pulmonary tuberculosis.
    Singh UK; Suman S
    J Indian Med Assoc; 1996 Oct; 94(10):381-4. PubMed ID: 9141878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?
    Tortajada C; Martínez-Lacasa J; Sánchez F; Jiménez-Fuentes A; De Souza ML; García JF; Martínez JA; Caylà JA;
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):276-81. PubMed ID: 15786890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
    Roy V; Tekur U; Chopra K
    Indian Pediatr; 1996 Apr; 33(4):287-91. PubMed ID: 8772902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary tuberculosis in children: its age-dependent aspects].
    Sánchez-Albisua I; Vidal López ML; del Castillo Martín F; Borque C; García-Miguel MJ; García-Hortelano J
    An Esp Pediatr; 1998 Mar; 48(3):251-5. PubMed ID: 9608084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The current situation and treatment of childhood tuberculosis].
    Takamatsu I
    Kekkaku; 1999 Apr; 74(4):365-75. PubMed ID: 10355223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tuberculosis in children.
    Chaulet P; Mazouni MS; Ait Khaled N
    Child Trop; 1992; (196-197):42-52. PubMed ID: 12345141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New technologies in the prevention, detection, diagnosis and treatment of tuberculosis in children].
    Mitinskaia LA
    Probl Tuberk; 2003; (1):19-24; discussion 24-5. PubMed ID: 12652978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.